{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:52:52Z","timestamp":1790776372755,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Breakthrough Cancer Research"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.canlet.2018.11.015","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T10:32:58Z","timestamp":1542882778000},"page":"475-482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Electrochemotherapy with cisplatin increases survival and induces immunogenic responses in murine models of lung cancer and colorectal cancer"],"prefix":"10.1016","volume":"442","author":[{"given":"Liam Friel","family":"Tremble","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan A.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Declan M.","family":"Soden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick F.","family":"Forde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.canlet.2018.11.015_bib1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0277-5379(91)90064-K","article-title":"Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses","volume":"27","author":"Mir","year":"1991","journal-title":"Eur. J. Canc."},{"issue":"11","key":"10.1016\/j.canlet.2018.11.015_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejcsup.2006.08.005","article-title":"Bases and rationale of the electrochemotherapy","volume":"4","author":"Mir","year":"2006","journal-title":"EJC Suppl."},{"issue":"11","key":"10.1016\/j.canlet.2018.11.015_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejcsup.2006.08.002","article-title":"Electrochemotherapy\u2013An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study","volume":"4","author":"Marty","year":"2006","journal-title":"EJC Suppl."},{"issue":"15","key":"10.1016\/j.canlet.2018.11.015_bib4","first-page":"3450","article-title":"Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice","volume":"55","author":"Sersa","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2018.11.015_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.canlet.2018.01.081","article-title":"ICOS activation in combination with electrochemotherapy generates effective anti-cancer immunological responses in murine models of primary, secondary and metastatic disease","volume":"420","author":"Tremble","year":"2018","journal-title":"Cancer Lett."},{"issue":"15","key":"10.1016\/j.canlet.2018.11.015_bib6","first-page":"3450","article-title":"Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum (II) in mice","volume":"55","author":"Ser\u0161a","year":"1995","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2018.11.015_bib7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.canlet.2018.11.015_bib8","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm.2028","article-title":"Activation of the NLRP3 inflammasome in dendritic cells induces IL-1\u03b2\u2013dependent adaptive immunity against tumors","volume":"15","author":"Ghiringhelli","year":"2009","journal-title":"Nat. Med."},{"issue":"14","key":"10.1016\/j.canlet.2018.11.015_bib9","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1158\/0008-5472.CAN-11-0950","article-title":"Human tumor cells killed by anthracyclines induce a tumor-specific immune response","volume":"71","author":"Fucikova","year":"2011","journal-title":"Cancer Res."},{"issue":"6062","key":"10.1016\/j.canlet.2018.11.015_bib10","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1126\/science.1208347","article-title":"Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice","volume":"334","author":"Michaud","year":"2011","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.canlet.2018.11.015_bib11","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1622","article-title":"Toll-like receptor 4\u2013dependent contribution of the immune system to anticancer chemotherapy and radiotherapy","volume":"13","author":"Apetoh","year":"2007","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.canlet.2018.11.015_bib12","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/cdd.2008.67","article-title":"The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death","volume":"15","author":"Panaretakis","year":"2008","journal-title":"Cell Death Differ."},{"issue":"4 Suppl","key":"10.1016\/j.canlet.2018.11.015_bib13","first-page":"145","article-title":"Electrochemotherapy: a new treatment of solid tumors","volume":"22","author":"Mir","year":"2003","journal-title":"J. Exp. Clin. Canc. Res."},{"issue":"8","key":"10.1016\/j.canlet.2018.11.015_bib14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.biopha.2006.07.016","article-title":"Electrochemotherapy a novel approach to the treatment of metastatic nodules on the skin and subcutaneous tissues","volume":"60","author":"Giardino","year":"2006","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.canlet.2018.11.015_bib15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejso.2007.05.016","article-title":"Electrochemotherapy in treatment of tumours","volume":"34","author":"Sersa","year":"2008","journal-title":"Eur. J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.canlet.2018.11.015_bib16","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/jso.23625","article-title":"Intraoperative electrochemotherapy of colorectal liver metastases","volume":"110","author":"Edhemovic","year":"2014","journal-title":"Eur. J. Surg. Oncol."},{"issue":"11","key":"10.1016\/j.canlet.2018.11.015_bib17","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1158\/0008-5472.CAN-11-0451","article-title":"Preclinical validation of electrochemotherapy as an effective treatment for brain tumors","volume":"71","author":"Agerholm-Larsen","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2018.11.015_bib18","series-title":"Clinical Aspects of Electroporation","first-page":"137","article-title":"Minimally invasive intraluminal tumor ablation","author":"Forde","year":"2011"},{"issue":"11","key":"10.1016\/j.canlet.2018.11.015_bib19","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ejso.2012.07.201","article-title":"Endoscopically targeted electrochemotherapy for the treatment of colorectal cancer","volume":"38","author":"Bourke","year":"2012","journal-title":"Eur. J. Surg. Oncol."},{"issue":"12","key":"10.1016\/j.canlet.2018.11.015_bib20","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s11517-012-0991-8","article-title":"Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumors","volume":"50","author":"Miklav\u010di\u010d","year":"2012","journal-title":"Med. Biol. Eng. Comput."},{"issue":"8","key":"10.1016\/j.canlet.2018.11.015_bib21","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ctrv.2013.03.007","article-title":"Review of current thermal ablation treatment for lung cancer and the potential of electrochemotherapy as a means for treatment of lung tumours","volume":"39","author":"Jahangeer","year":"2013","journal-title":"Cancer Treat Rev."},{"issue":"3","key":"10.1016\/j.canlet.2018.11.015_bib22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1515\/raon-2017-0034","article-title":"In vitro and in vivo evaluation of electrochemotherapy with trans-platinum analogue trans-[PtCl2(3-Hmpy)2]","volume":"51","author":"Kranjc","year":"2017","journal-title":"Radiol. Oncol."},{"key":"10.1016\/j.canlet.2018.11.015_bib23","doi-asserted-by":"crossref","DOI":"10.4161\/onci.28131","article-title":"Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells","volume":"3","author":"Calvet","year":"2014","journal-title":"OncoImmunology"},{"issue":"4","key":"10.1016\/j.canlet.2018.11.015_bib24","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1440-1827.2010.02514.x","article-title":"Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T\u2010cell lymphoma (AITL)","volume":"60","author":"Niino","year":"2010","journal-title":"Pathol. Int."},{"issue":"12","key":"10.1016\/j.canlet.2018.11.015_bib25","first-page":"1509","article-title":"Clinical evaluation of macrophages in cancer: role in treatment, modulation and challenges","volume":"66","author":"Tremble","year":"2017"},{"issue":"8","key":"10.1016\/j.canlet.2018.11.015_bib26","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1080\/0284186X.2017.1290274","article-title":"Electrochemotherapy and calcium electroporation inducing a systemic immune response with local and distant remission of tumors in a patient with malignant melanoma - a case report","volume":"56","author":"Falk","year":"2017","journal-title":"Acta Oncol."},{"issue":"5","key":"10.1016\/j.canlet.2018.11.015_bib27","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.canlet.2018.11.015_bib28","doi-asserted-by":"crossref","first-page":"e1008842","DOI":"10.1080\/2162402X.2015.1008842","article-title":"Assessing a novel immuno-oncology-based combination therapy: ipilimumab plus electrochemotherapy","volume":"4","author":"Mozzillo","year":"2015","journal-title":"OncoImmunology"},{"issue":"8","key":"10.1016\/j.canlet.2018.11.015_bib29","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00262-016-1856-z","article-title":"Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis","volume":"65","author":"Heppt","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.canlet.2018.11.015_bib30","series-title":"Electrochemotherapy with Anti-PD-1 Treatment Induced Durable Complete Response in Heavily Pretreated Metastatic Melanoma Patient","author":"Karaca","year":"2017"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383518306803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383518306803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T10:18:38Z","timestamp":1545819518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383518306803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":30,"alternative-id":["S0304383518306803"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2018.11.015","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electrochemotherapy with cisplatin increases survival and induces immunogenic responses in murine models of lung cancer and colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2018.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}